Rubicon Organics Stock Today

ROMJ Stock  CAD 0.49  0.01  2.08%   

Performance

6 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 18

 
High
 
Low
Low
Rubicon Organics is selling for under 0.49 as of the 18th of July 2024; that is 2.08 percent increase since the beginning of the trading day. The stock's lowest day price was 0.49. Rubicon Organics has less than a 18 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Rubicon Organics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of July 2022 and ending today, the 18th of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Rubicon Organics Inc. produces and sells organic cannabis in Canada. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. RUBICON ORGANICS operates under Drug ManufacturersSpecialty Generic classification in Exotistan and is traded on Commodity Exchange.. The company has 56.19 M outstanding shares of which 13.94 K shares are at this time shorted by private and institutional investors with about 0.12 days to cover all short positions. More on Rubicon Organics

Moving against Rubicon Stock

  0.51ORC-A Orca Energy GroupPairCorr
  0.49BUI Buhler IndustriesPairCorr

Rubicon Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Rubicon Organics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Rubicon Organics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaNatural Foods (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Natural Foods, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Rubicon Organics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Rubicon Organics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Rubicon Organics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Rubicon Organics' financial leverage. It provides some insight into what part of Rubicon Organics' total assets is financed by creditors.
Liquidity
Rubicon Organics cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Rubicon Organics has accumulated 758.46 K in total debt with debt to equity ratio (D/E) of 0.22, which may suggest the company is not taking enough advantage from borrowing. Rubicon Organics has a current ratio of 6.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Rubicon Organics until it has trouble settling it off, either with new capital or with free cash flow. So, Rubicon Organics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rubicon Organics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rubicon to invest in growth at high rates of return. When we think about Rubicon Organics' use of debt, we should always consider it together with cash and equity.

Change To Operating Activities

694,049
Rubicon Organics (ROMJ) is traded on TSX Venture Exchange in Canada and employs 180 people. Rubicon Organics is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rubicon Organics's market, we take the total number of its shares issued and multiply it by Rubicon Organics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Rubicon Organics operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 56.19 M outstanding shares of which 13.94 K shares are at this time shorted by private and institutional investors with about 0.12 days to cover all short positions. Rubicon Organics has accumulated about 4.22 M in cash with 6.79 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Rubicon Organics Probability Of Bankruptcy
Ownership Allocation
Rubicon Organics has a total of 56.19 Million outstanding shares. Rubicon Organics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Rubicon Ownership Details

Rubicon Organics Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Rubicon Organics market risk premium is the additional return an investor will receive from holding Rubicon Organics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Rubicon Organics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Rubicon Organics' alpha and beta are two of the key measurements used to evaluate Rubicon Organics' performance over the market, the standard measures of volatility play an important role as well.

Rubicon Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Rubicon Organics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Dashboard Now

   

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments
All  Next Launch Module

Rubicon Organics Corporate Management

Elected by the shareholders, the Rubicon Organics' board of directors comprises two types of representatives: Rubicon Organics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rubicon. The board's role is to monitor Rubicon Organics' management team and ensure that shareholders' interests are well served. Rubicon Organics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rubicon Organics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Additional Tools for Rubicon Stock Analysis

When running Rubicon Organics' price analysis, check to measure Rubicon Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rubicon Organics is operating at the current time. Most of Rubicon Organics' value examination focuses on studying past and present price action to predict the probability of Rubicon Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rubicon Organics' price. Additionally, you may evaluate how the addition of Rubicon Organics to your portfolios can decrease your overall portfolio volatility.